Clinical Manifestations and Management of Fibrotic Pulmonary Sarcoidosis.

advanced pulmonary sarcoidosis fibrotic pulmonary sarcoidosis pulmonary fibrosis sarcoidosis

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
31 Dec 2023
Historique:
received: 13 11 2023
revised: 22 12 2023
accepted: 27 12 2023
medline: 11 1 2024
pubmed: 11 1 2024
entrez: 11 1 2024
Statut: epublish

Résumé

Fibrotic pulmonary sarcoidosis represents a distinct and relatively uncommon manifestation within the spectrum of sarcoidosis and has substantial morbidity and mortality. Due to the scarcity of research focused on this specific disease subtype, our current understanding of pathogenesis and optimal management remains constrained. This knowledge gap underscores the need for further investigation into areas such as targeted therapies, lung transplantation, and quality of life of patients with fibrotic pulmonary sarcoidosis. The primary aim of this review is to discuss recent developments within the realm of fibrotic pulmonary sarcoidosis to foster a more comprehensive understanding of the underlying mechanisms, prognosis, and potential treatment modalities.

Identifiants

pubmed: 38202248
pii: jcm13010241
doi: 10.3390/jcm13010241
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Auteurs

Jin Sun Kim (JS)

Department of Thoracic Medicine and Surgery, Temple University Hospital, Philadelphia, PA 19140, USA.

Rohit Gupta (R)

Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine, Temple University Hospital, Philadelphia, PA 19140, USA.

Classifications MeSH